A process-led CRM that helps B2B sales teams standardize how opportunities move and managers improve execution.
Editorial verdict
A strong specialist choice for process-led B2B teams—especially in Europe—that want disciplined sales methodology, actionable analytics, and hands-on implementation support without enterprise CRM weight.
Where it earns its place
Strong process design and sales methodology support
Useful manager visibility and win-probability discipline
Hands-on implementation and strong Central European fit
Where the trade-offs appear
Smaller integration ecosystem than global platform leaders
Less suitable for organizations seeking a broad all-department suite
Editorial conclusion · Not vendor-approved · Evidence last checked 06/08/2026
02
How the product behaves in practice
Operating model
What has to be true
Livespace is built around a defined B2B sales method: stages, qualification, activities and manager visibility. Its value rises when a team wants to improve how it sells, not merely store contacts.
Implementation reality
Where the work sits
The implementation should translate the real sales process into stages, required information and automations. Hands-on support is a meaningful advantage for teams without a large RevOps function.
Buying advice
How to evaluate it
Ask the vendor to model one genuine opportunity, one management review and one handoff. Compare integration coverage against the tools the team already relies on.
Product evidence
Capabilities we verified
Structured B2B process
Qualification and scoring
Automation and tasks
Sales analytics
Before you sign
Questions for the demo
How will our qualification method be represented?
Which integrations are native versus Zapier-based?
What does implementation support include?
Category scorecard
How Livespace scores for this context
Team fit
86
Workflow
87
Usability
82
Automation
74
Reporting
82
Administration
78
Total cost
80
Source trail
Read the underlying evidence
Product capabilities and pricing are checked against vendor materials. Customer outcomes are vendor-published claims and are treated as directional—not independent proof.